Merck & Co., Inc. Licenses Ariadne Genomics' MedScan(TM) Text-to Knowledge Suite

22-Nov-2005

Ariadne Genomics, Inc. announced that it has granted Merck & Co., Inc. of Whitehouse Station, New Jersey, a corporate-wide license for MedScan(TM) Text-to-Knowledge Suite software, Ariadne's automated scientific text processing tool. MedScan extracts information from text using state-of-the-art natural language processing (NLP) technology and converts scientific text into a database of protein functional relationships.

MedScan Text-to-Knowledge Suite software automatically extracts pathway-related information from text. Data regarding regulation, expression regulation, binding, molecular transport, protein modification, molecular synthesis etc. are recognized in the text and stored in XML files.

Other news from the department research and development

Most read news

More news from our other portals